CASTOLDI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 5.387
AS - Asia 3.085
EU - Europa 2.341
SA - Sud America 487
AF - Africa 76
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 11.388
Nazione #
US - Stati Uniti d'America 5.229
SG - Singapore 942
CN - Cina 929
DE - Germania 448
VN - Vietnam 384
BR - Brasile 377
HK - Hong Kong 367
IT - Italia 345
RU - Federazione Russa 330
SE - Svezia 293
IE - Irlanda 242
GB - Regno Unito 170
UA - Ucraina 157
CA - Canada 110
IN - India 107
FR - Francia 103
FI - Finlandia 62
BD - Bangladesh 58
AT - Austria 45
AR - Argentina 42
ID - Indonesia 39
TR - Turchia 39
IQ - Iraq 35
KR - Corea 32
MX - Messico 27
DK - Danimarca 25
EC - Ecuador 23
NL - Olanda 23
ZA - Sudafrica 23
PK - Pakistan 22
PL - Polonia 22
BE - Belgio 19
ES - Italia 18
JP - Giappone 16
PH - Filippine 16
UZ - Uzbekistan 16
CO - Colombia 14
SA - Arabia Saudita 13
MA - Marocco 12
VE - Venezuela 12
MY - Malesia 11
CZ - Repubblica Ceca 7
KE - Kenya 7
PE - Perù 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
JO - Giordania 6
OM - Oman 6
AU - Australia 5
DZ - Algeria 5
IR - Iran 5
LB - Libano 5
NP - Nepal 5
RO - Romania 5
TN - Tunisia 5
AO - Angola 4
AZ - Azerbaigian 4
EG - Egitto 4
EU - Europa 4
JM - Giamaica 4
LT - Lituania 4
PA - Panama 4
AL - Albania 3
CL - Cile 3
DO - Repubblica Dominicana 3
MN - Mongolia 3
NG - Nigeria 3
PS - Palestinian Territory 3
PT - Portogallo 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
QA - Qatar 1
Totale 11.382
Città #
Ann Arbor 971
Singapore 525
Ashburn 504
Hong Kong 362
Woodbridge 350
Frankfurt am Main 317
San Jose 301
Fairfield 279
Chandler 259
Beijing 242
Dublin 232
Houston 212
Wilmington 211
Hangzhou 159
Jacksonville 152
New York 139
Dearborn 123
Seattle 118
Ho Chi Minh City 104
Cambridge 90
Santa Clara 88
Dallas 87
Los Angeles 86
Milan 86
Princeton 84
Hanoi 82
Chicago 81
Nanjing 57
Hefei 53
Lauterbourg 47
The Dalles 46
Shanghai 45
Altamura 44
Lawrence 39
São Paulo 39
Vienna 36
Moscow 34
Seoul 30
Buffalo 29
Dong Ket 28
Helsinki 28
San Diego 27
Guangzhou 26
Lachine 26
London 26
Council Bluffs 24
Orem 24
Ottawa 23
Toronto 23
Jakarta 22
Lissone 22
Boardman 21
Munich 21
Nanchang 20
Brussels 19
Falls Church 19
Warsaw 19
Shenyang 18
Montreal 17
Andover 15
Baghdad 15
Fremont 14
Hải Dương 14
Tokyo 14
Dhaka 12
Hebei 12
Tashkent 12
Washington 12
Atlanta 11
Phoenix 11
Jinan 10
Rio de Janeiro 10
Salvador 10
Zhengzhou 10
Brooklyn 9
Da Nang 9
Delhi 9
Haiphong 9
Johannesburg 9
Manchester 9
Mumbai 9
Norwalk 9
Rome 9
Salt Lake City 9
San Francisco 9
Tianjin 9
Brasília 8
Edmonton 8
Huizen 8
Poplar 8
Chennai 7
Columbus 7
Detroit 7
Istanbul 7
Kunming 7
New Delhi 7
Quito 7
Stockholm 7
Tampa 7
Changsha 6
Totale 7.587
Nome #
NAFLD/NASH in patients with type 2 diabetes and related treatment options 568
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 537
Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: Potential role in renal fibrosis 495
Urinary exosomes and diabetic nephropathy: a proteomic approach 441
Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats 348
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 347
Fasting whole-body energy homeostasis and hepatic energy metabolism in nondiabetic humans with fatty liver 318
Risk Factors for 6-month Mortality among the Oldest Old Orthogeriatric Patients 313
Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: Evidence for blood pressure independent effect 308
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 301
Brachial and central blood pressure in HIV-infected subjects 299
Transcriptomic Profile of Human Osteoblast-like Cells Grown on Trabecular Titanium 284
Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy 271
Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension 264
Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats 263
Angiotensina e fibrosi renale: ruolo dei microRNA 258
Association between serum values of C-reactive protein and cytokine production in whole blood of patients with Type 2 diabetes 251
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes 249
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 246
Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells 246
[OP.4B.05] MIR-30A-3P EXPRESSION IN THE HEARTS OF DIABETIC RATS 245
Oxidative stress biomarkers and chromogranin A in uremic patients: effects of dialytic treatment 241
Arterial structure and function in AIDS patients: the impact of renal damage. 235
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy 232
TIMP1 plasma levels are correlated with arterial stiffening process. 227
MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension 222
Angiotensin type 2 and mas receptor activation prevents myocardial fibrosis and hypertrophy through the reduction of inflammatory cell infiltration and local sympathetic activity in angiotensin ii‐dependent hypertension 214
Role of the renal nerves in the response by atrial natriuretic factor to acute volume expansion 209
Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect. 208
Effects of adenosine-receptor agonists on renin release in anaesthetized rats 207
La frattura di femore nel paziente anziano fragile. L'esperienza della Sezione di Ortogeriatria dell'Ospedale San Gerardo di Monza 204
Role of the renal nerves and angiotensin II in the renal function curve 203
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 200
Radiofrequency-based carotid wall tracking: a comparison between two different systems 194
Neuroprotection after ischemic stroke by activation of angiotensin receptor type 2: Why clinical data do not fit the paradigm? 194
SGLT2 INHIBITION PREVENTS RENAL FIBROSIS IN CYCLOSPORINE NEPHROPATHY 191
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation 189
Angiotensin II Modulates Calcium/Phosphate Excretion in Experimental Model of Hypertension: Focus on Bone 184
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats 178
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 173
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 173
Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats 164
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 161
Comparison of two radiofrequency-based systems for assessment of local carotid stiffness. 154
Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models 153
EMPAGLIFLOZIN ADMINISTRATION PREVENTS THE DEVELOPMENT OF MYOCARDIAL FIBROSIS IN ANGIOTENSIN II-DEPENDENT HYPERTENSION 139
Totale 11.701
Categoria #
all - tutte 35.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 0 0 0 0 0 61 102
2021/2022729 48 89 79 75 52 53 34 31 36 56 56 120
2022/20231.122 128 390 123 86 76 163 4 53 61 7 24 7
2023/2024759 26 26 35 50 83 234 146 25 32 12 8 82
2024/20251.588 88 139 60 78 166 68 126 54 114 247 149 299
2025/20263.768 502 243 351 418 474 220 603 186 366 377 28 0
Totale 11.701